Skip to main content

ADVERTISEMENT

prostate cancer

News
03/25/2020
Busch Center First in State to Offer Groundbreaking TULSA Procedure  ALPHARETTA, Ga. (March 25, 2020) – Busch Center, the leading prostate MRI facility in America, is now offering a groundbreaking cancer treatment procedure, known as...
Busch Center First in State to Offer Groundbreaking TULSA Procedure  ALPHARETTA, Ga. (March 25, 2020) – Busch Center, the leading prostate MRI facility in America, is now offering a groundbreaking cancer treatment procedure, known as...
Busch Center First in State to...
03/25/2020
IO Learning
From the Field
09/20/2019
Frank dela Rama, RN, MS, AOCNS, AGN-BC
Abstract: An Integrated Prostate Cancer Program was developed and implemented at the Palo Alto Medical Foundation for Health Care, Research and Education in 2006. The Prostate Program offers surgery, radiation...
Abstract: An Integrated Prostate Cancer Program was developed and implemented at the Palo Alto Medical Foundation for Health Care, Research and Education in 2006. The Prostate Program offers surgery, radiation...
...
09/20/2019
Journal of Clinical Pathways
Research in Review
10/16/2016
JCP Editors
Adjuvant radiation therapy may be more effective at treating prostate cancer than no treatment or salvage radiation therapy, according to a recent study published in BJU International. Studies have demonstrated...
Adjuvant radiation therapy may be more effective at treating prostate cancer than no treatment or salvage radiation therapy, according to a recent study published in BJU International. Studies have demonstrated...
...
10/16/2016
Journal of Clinical Pathways
Department
10/04/2016
JCP Editors
In the first study to evaluate patient-reported outcomes from the NRG Oncology/RTOG 0415 trial, treatment with hypofractionated radiation therapy offers similar health-related quality of life (HRQoL) outcomes in...
In the first study to evaluate patient-reported outcomes from the NRG Oncology/RTOG 0415 trial, treatment with hypofractionated radiation therapy offers similar health-related quality of life (HRQoL) outcomes in...
In the...
10/04/2016
Journal of Clinical Pathways
News
09/28/2016
Newswise — BOSTON, September 26, 2016 -- High dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity and excellent cancer...
Newswise — BOSTON, September 26, 2016 -- High dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity and excellent cancer...
Newswise — BOSTON, September 26,...
09/28/2016
IO Learning
Quiz
09/22/2016
JCP Editors
A study published in the New England Journal of Medicine showed that localized prostate cancer is more likely to metastasize if patients receive which of the following treatments? radiation therapy active...
A study published in the New England Journal of Medicine showed that localized prostate cancer is more likely to metastasize if patients receive which of the following treatments? radiation therapy active...
A...
09/22/2016
Journal of Clinical Pathways
Research in Review
09/21/2016
JCP Editors
While survival at 10 years is similar, localized prostate cancer may be more likely to metastasize in men receiving active surveillance compared with those who have surgery or radiation therapy, according to results...
While survival at 10 years is similar, localized prostate cancer may be more likely to metastasize in men receiving active surveillance compared with those who have surgery or radiation therapy, according to results...
While...
09/21/2016
Journal of Clinical Pathways
Research in Review
08/30/2016
JCP Editors
A larger number of docetaxel cycles may improve survival among men with metastatic castration-resistant prostate cancer (mCRPC), according to a post-hoc analysis of phase III clinical trial results. Scientists and...
A larger number of docetaxel cycles may improve survival among men with metastatic castration-resistant prostate cancer (mCRPC), according to a post-hoc analysis of phase III clinical trial results. Scientists and...
A...
08/30/2016
Journal of Clinical Pathways
Research in Review
08/21/2016
JCP Editors
Radiotherapy and radical prostatectomy resulted in similar survival outcomes among men with aggressive prostate cancer, according to the results of a comparative analysis published in European Urology. Currently,...
Radiotherapy and radical prostatectomy resulted in similar survival outcomes among men with aggressive prostate cancer, according to the results of a comparative analysis published in European Urology. Currently,...
...
08/21/2016
Journal of Clinical Pathways
Research in Review
08/02/2016
JCP Editors
Patient outcomes differed widely based on which radiation therapy (RT) option was used to treat prostate cancer, according to a study published in Cancer Treatment Reviews. Treatment for prostate cancer, a prevalent...
Patient outcomes differed widely based on which radiation therapy (RT) option was used to treat prostate cancer, according to a study published in Cancer Treatment Reviews. Treatment for prostate cancer, a prevalent...
...
08/02/2016
Journal of Clinical Pathways